| Issuer | % of Class | Filed |
|---|---|---|
|
AN2 Therapeutics, Inc.
13G/A
Amendment 3
ANTX · 037326105
|
6.2% |
11/13/2026
Event 9/30/2026
|
|
AN2 Therapeutics, Inc.
13G/A
Amendment 2
ANTX · 037326105
|
7.9% |
2/13/2026
Event 12/31/2025
|
|
AN2 Therapeutics, Inc.
13G/A
Amendment 1
ANTX · 037326105
|
6.2% |
2/13/2025
Event 12/31/2024
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.